UiPath Inc.'s directors and executives urged the Delaware Chancery Court on Tuesday to throw out a shareholder derivative suit accusing them of misleading investors and trading on inside information, while shareholder Scott Rudolph argued the board was too conflicted to fairly decide whether the company should pursue the claims itself.

El proveedor de la plataforma de automatización de inteligencia artificial informó una notable venta de acciones internas.

UiPath (PATH) has fallen about 27% from its one-month high, though it is still up 34% over three months. The stock trades at 19.5 times earnings, against an S&P 500 median of 22.6. For a software company growing faster than most of the market, that looks like a gift. The question is whether investors see an AI threat the numbers do not show yet.

UiPath desarrolla software de orquestación de inteligencia artificial y automatización empresarial, conectando flujos de trabajo digitales, aplicaciones, agentes y personas dentro de NYSE Composite.

UiPath, Inc. (NYSE:PATH - Get Free Report) insider Raghavendra Malpani sold 40,464 shares of UiPath stock in a transaction on Thursday, September 17th. The shares were sold at an average price of $14.00, for a total transaction of $566,496.00. Following the completion of the sale, the insider owned 1,582,213 shares in the company, valued at approximately $22,150,982. This trade represents a 2.49% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.